MoneyWorks4Me

Gland Pharma informs about analyst meet

11 Jun 2021 Evaluate

Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that it has enclosed the schedule of Analyst/ Institutional Investor Meetings with the Company. The schedule of the meetings is subject to change and the change may occur due to exigencies on the part of Investor/ Analyst/ Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.25
Dr. Reddys Labs. 1216.95
Cipla 1311.35
Lupin 1958.65
Zydus Lifesciences 1115.35
View more..